CingulateCING

Cingulate

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Dr. Shane J. Schaffer, Pharm.D.

$4.8M

Market Cap • 20/05/2024

2021

(há 3 anos)
Fundação

2021

(3 years ago)
IPO

NASDAQ

Listagem
Flag of US

Kansas

Sede • Kansas

15

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

CINGSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-1%

1 dia

17/05/2024

-0%

1 semana

13/05/2024

-11%

1 mês

22/04/2024

-96%

1 ano

22/05/2023

10 anos

Histórico